Mylan NV (NASDAQ:MYL)

21.00
Delayed Data
As of Sep 19
 -0.29 / -1.36%
Today’s Change
16.63
Today|||52-Week Range
39.59
-23.36%
Year-to-Date

Today’s Trading

Previous close21.29
Today’s open21.32
Day’s range20.91 - 21.45
Volume4,230,168
Average volume (3 months)7,369,457
Market cap$11.2B
Data as of 4:00pm ET, 09/19/2019

Growth & Valuation

Earnings growth (last year)-46.92%
Earnings growth (this year)-6.30%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)-4.02%
P/E ratio350.0
Price/Sales1.24
Price/Book0.92

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-0.05-0.07%
ALNYAlnylam Pharmaceutic...-0.89-1.04%
IONSIonis Pharmaceutical...-0.17-0.27%
GLPGGalapagos NV+0.82+0.52%
Data as of 4:00pm ET, 09/19/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)$1.13
Annual revenue (last year)$11.4B
Annual profit (last year)$352.5M
Net profit margin3.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts